© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 16, 1195-1196,
August 21, 2002
© 2002 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Three physicians have been selected by the American Society for Therapeutic Radiology and Oncology to receive the Gold Medal, the society’s highest honor.Steven Leibel, M.D., of Memorial Sloan-Kettering Cancer Center in New York, was recognized for developing high-dose conformal radiation therapy for prostate cancer.
Victor Marcial, M.D., of the University of Puerto Rico School of Medicine and University Hospital in San Juan, was named for his work in planning and conducting a community-wide cancer control program for gynecological cancer. Marcial also played a role in the founding of ASTRO.
Marvin Rotman, M.D., was recognized for his contributions to the treatment of gynecological cancer and choroidal melanoma.
The physicians will be honored in October during the society’s annual meeting in New Orleans.
Schottenfeld Awarded
David Schottenfeld, M.D., has received the Abraham Lilienfeld Award, the highest honor from the American College of Epidemiology. The award recognizes Schottenfeld’s achievement and leadership in cancer epidemiology.
Schottenfeld is John G. Searle professor of epidemiology at the University of Michigan School of Public Health.
Trapido Named
Edward Trapido, Sc.D., has been named associate director of the Epidemiology and Genetics Research Program of the Division of Cancer Control and Population Sciences at the National Cancer Institute.
Trapido will oversee the development of the Cancer Family Registries, the Cancer Genetics Network, and the new Cohort Consortium. He will also work with new NCI initiatives to identify cancer-related health disparities.
Trapido is leaving his position as professor and vice chair of the Department of Epidemiology and Public Health at the University of Miami School of Medicine. He is also associate director for Cancer Prevention and Control at the Sylvester Comprehensive Cancer Center.
Gleave Recognized
Martin Gleave, M.D., has received the Young Investigator Award from the Society of Urologic Oncology. Gleave is professor of surgery and urology at the University of British Columbia and director of clinical research at the Prostate Centre at Vancouver General Hospital.
|
His research focuses on mechanisms of metastasis of prostate cancer as well as novel treatments for localized and advanced disease.
Ruckdeschel to Head Karmanos
John C. Ruckdeschel, M.D., has been named director, president, and chief executive officer of the Barbara Ann Karmanos Cancer Institute in Detroit, Mich.
He will also serve as president of the Barbara Ann Karmanos Cancer Foundation; director of the Meyer L. Prentis Comprehensive Cancer Center; associate dean, cancer affairs at Wayne State University School of Medicine and director of WSU’s Cancer Institute Cancer Institute; and president of the cancer hospital and senior vice president at the Detroit Medical Center.
Ruckdeschel was previously director and chief executive officer of the H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida in Tampa.
Dalton to Head Moffitt
William Dalton, M.D., Ph.D., will succeed John C. Ruckdeschel, M.D., as director and chief executive officer of the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Fla.
Dalton was previously dean of the College of Medicine at the University of Arizona. He has also served as associate center director for clinical investigations and deputy director at H. Lee Moffitt.
His research focuses on how the tumor environment promotes cancer growth and prevents response to treatment.
Bookman Named
Michael A. Bookman, M.D., has been named medical director of Ambulatory Care and Clinical Information Systems at Fox Chase Cancer Center in Philadelphia. There, he will oversee clinical services and implement medically related information systems.
Bookman will continue in his current role as director of the protocol management facility. His research focuses on ovarian, endometrial, and cervical cancers as well as investigational therapy.
New Faulty at Roswell Park
Roswell Park Cancer Institute in Buffalo, N.Y., has added two new medical oncologists to its staff in the Department of Medicine.
Marwan G. Fakih, M.D., will join the Gastrointestinal Cancer Division. He was previously professor of medicine at the University of Pittsburgh School of Medicine. His research focuses on the development of new therapies for gastrointestinal cancers.
Tracey L. O’Connor, M.D., will join the Breast Cancer Division. She recently completed a fellowship in medical oncology at Roswell Park. Her research focuses on new treatments for breast cancer and supportive care therapies for advanced disease.
Marshall Appointed
James R. Marshall, Ph.D., has been appointed senior vice president for population sciences and cancer prevention at Roswell Park Cancer Institute. He will be responsible for overseeing the expansion of prevention and population sciences programs.
Marshall comes to RPCI from the Arizona Cancer Center in Tucson, where he was associate director of cancer prevention and control and professor of public health and medicine at the University of Arizona College of Medicine. He has also served on the faculty at the University at Buffalo, State University of New York.
His research focuses on the identification and testing of various chemoprevention approaches in human populations.
Larson Joins Health Cooperative
Eric B. Larson, M.D., director of the University of Washington Medical Center, has been named director of the Center for Health Studies for the Group Health Cooperative.
The center is a research institution that promotes the prevention and effective treatment of major health problems.
Gustin Appointed
David M. Gustin, M.D., has been appointed assistant professor in the hematology/oncology section at the University of Chicago, where he will lead chemoprevention efforts.
Gustin comes from the University of Illinois at Chicago.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||